150 related articles for article (PubMed ID: 32626928)
1. MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway.
Zhang H; Liang F; Yue J; Liu P; Wang J; Wang Z; Li H; Cheng D; Du J; Zhang K; Du P
Int J Oncol; 2020 Aug; 57(2):540-549. PubMed ID: 32626928
[TBL] [Abstract][Full Text] [Related]
2. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
3. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B.
Chen T; Lei S; Zeng Z; Pan S; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Int J Mol Med; 2020 Mar; 45(3):886-896. PubMed ID: 31985024
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑125a‑5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1.
Zha Z; Li J
Int J Mol Med; 2020 Nov; 46(5):1849-1861. PubMed ID: 33000203
[TBL] [Abstract][Full Text] [Related]
6. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
Guo R; Hu T; Liu Y; He Y; Cao Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
[TBL] [Abstract][Full Text] [Related]
9. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
10. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
12. lncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer.
Sun JG; Li XB; Yin RH; Li XF
Mol Med Rep; 2020 Dec; 22(6):4567-4578. PubMed ID: 33173977
[TBL] [Abstract][Full Text] [Related]
13. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
Fan Y; Wang K
Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998
[TBL] [Abstract][Full Text] [Related]
14. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
15. The Interplay of MicroRNA-34a, LGR4, EMT-Associated Factors, and MMP2 in Regulating Uveal Melanoma Cells.
Hou Q; Han S; Yang L; Chen S; Chen J; Ma N; Wang C; Tang J; Chen X; Chen F; Dong XDE; Tu L
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4503-4510. PubMed ID: 31661551
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
Park GB; Ko HS; Kim D
Mol Med Rep; 2017 Aug; 16(2):1826-1836. PubMed ID: 28627617
[TBL] [Abstract][Full Text] [Related]
17. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
18. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
Chen XB; Li W; Chu AX
J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma.
Deng J; Wang W; Yu G; Ma X
Mol Med Rep; 2019 Nov; 20(5):4023-4032. PubMed ID: 31545414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
